Mohan Bala

SVP, Chief Development Officer, Mersana Therapeutics (United States).

Companies

Mersana Therapeutics (United States)SVP, Chief Development Officer Sep 7, 2023 to now¹

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Jan 6, 2026U 2,927 shares of Mersana Therapeutics (United States)²
Oct 27, 2025Sold 77 shares at $9.90 of Mersana Therapeutics (United States)³
Oct 25, 2025Exercised options 250 shares of Mersana Therapeutics (United States)³
Jan 16, 2025Sold 5,939 shares at $0.58 of Mersana Therapeutics (United States)⁴
Jan 15, 2025Exercised options 14,583 shares of Mersana Therapeutics (United States)⁴
Jan 14, 2025Sold 3,253 shares at $0.66 of Mersana Therapeutics (United States)⁵
Jan 13, 2025Exercised options 8,750 shares of Mersana Therapeutics (United States)⁵
Oct 28, 2024Sold 1,884 shares at $1.90 of Mersana Therapeutics (United States)⁶
Oct 25, 2024Exercised options 6,250 shares of Mersana Therapeutics (United States)⁶
Oct 3, 2024Sold 5,598 shares at $1.96 of Mersana Therapeutics (United States)⁷
Oct 2, 2024Sold 8,089 shares at $2.00 of Mersana Therapeutics (United States)⁷
Oct 1, 2024Exercised options 50,000 shares of Mersana Therapeutics (United States)⁷
Jan 16, 2024Sold 3,431 shares at $2.71 of Mersana Therapeutics (United States)⁸
Jan 13, 2024Exercised options 8,750 shares of Mersana Therapeutics (United States)⁸
Oct 26, 2023Sold 1,912 shares at $1.13 of Mersana Therapeutics (United States)⁹
Oct 25, 2023Exercised options 6,250 shares of Mersana Therapeutics (United States)⁹

The numbers on this page point here. Each one links to the record it came from.